Active Recombinant Rat Ctsk Protein

Cat.No. : CTSK-440R
Product Overview : Recombinant Rat Ctsk Protein (115-329 aa) without tag was expressed in E. coli.
  • Specification
  • Gene Information
  • Related Products
  • Download
Description : Cathepsin K, a member of the papain cysteine proteinase family is the predominant proteinase responsible for the resorption of the bone matrix. Cathepsin cleaves proteins such as collagen type I, collagen type II and osteonectin, thereby playing a role in bone remodeling and resorption in osteoporosis, osteolytic bone metastasis and rheumatoid arthritis (Bromme and Okamoto, 1995; Drake, F. et al 1996; Bossard et al, 1996).
Source : E. coli
Species : Rat
Bio-activity : The specific activity is >500 mU/mg (1U = 1 μmole/min/mg) as measured by Cathepsin K Activity Assay Kit.
Molecular Mass : 23.5 kDa (115-329 aa)
Purity : ≥ 90% by SDS–PAGE analysis
Usage : For Research Use Only! Not For Use in Humans.
Storage : Store at -80 centigrade
Storage Buffer : 0.5 mg/mL solution in 25 mM Na2HPO4 and 500 mM NaCl (pH 7.0) with 50% glycerol.
Shipping : Dry Ice
Protein length : 115-329
Gene Name : Ctsk cathepsin K [ Rattus norvegicus (Norway rat) ]
Official Symbol : Ctsk
Synonyms : Ctsk; cathepsin K; cathepsin K; EC 3.4.22.38; CTSK; CTSO3; CTSO
Gene ID : 29175
mRNA Refseq : NM_031560
Protein Refseq : NP_113748
UniProt ID : O35186

Not For Human Consumption!

Inquiry

  • Reviews
  • Q&As

Customer Reviews (3)

Write a review
Reviews
09/13/2019

    This guidance can help researchers design and execute their experiments more effectively, ensuring reliable and accurate results.

    01/27/2019

      They have a deep understanding of the CTSK protein and can provide valuable insights into its characteristics, properties, and optimal experimental conditions.

      12/14/2016

        the manufacturer offers outstanding technical support, serving as a valuable resource to resolve any issues that may arise during my research.

        Q&As (5)

        Ask a question
        Can CTSK be a target for the development of novel therapeutics for periodontal diseases? 10/10/2022

        Yes, CTSK inhibitors are being investigated for their potential in preventing bone loss associated with periodontal diseases.

        How does CTSK contribute to the progression of atherosclerosis, and can it be a therapeutic target for cardiovascular diseases? 01/22/2020

        CTSK has been linked to vascular calcification in atherosclerosis, and inhibiting its activity may have potential as a therapeutic strategy for cardiovascular diseases.

        How might CTSK inhibitors impact the treatment landscape for bone metastasis in cancer patients? 03/26/2018

        CTSK inhibitors could potentially be used to limit bone destruction in cancer patients with bone metastasis, improving their quality of life.

        Are there any other medical conditions where CTSK inhibitors could be beneficial? 07/29/2017

        CTSK inhibitors are being explored for potential therapeutic applications in conditions like rheumatoid arthritis and certain cancers due to their involvement in tissue remodeling.

        Are there diagnostic applications for CTSK in identifying bone-related disorders? 11/22/2016

        While CTSK is not currently used as a diagnostic marker, its levels and activity could potentially be explored for diagnostic purposes in the future.

        Ask a Question for All Ctsk Products

        Required fields are marked with *

        My Review for All Ctsk Products

        Required fields are marked with *

        0

        Inquiry Basket

        cartIcon
        logo

        FOLLOW US

        Terms and Conditions        Privacy Policy

        Copyright © 2024 Creative BioMart. All Rights Reserved.

        Contact Us

        • /
        • Service lnquiry:

        Stay Updated on the Latest Bioscience Trends